Dynavax Technologies | Eget Kapital Och Reservfonder



Equity Capital And Reserves Ändra Datum
AbbVie USD 3.32B 2.71B 2024-12
Adma Biologics USD 349.02M 117.13M 2024-12
Amgen USD 5.88B 1.65B 2024-12
AstraZeneca USD 40.87B 66M 2024-12
Biogen USD 16.72B 357.1M 2024-12
BioMarin Pharmaceutical USD 5.66B 244.59M 2024-12
Bristol-Myers Squibb USD 16.34B 807M 2024-12
Dynavax Technologies USD 596.8M 84.63M 2024-12
Gilead Sciences USD 19.33B 856M 2024-12
Glaxosmithkline GBP 13.67B 337M 2024-12
Merck USD 46.31B 1.81B 2024-12
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
Novartis USD 44.05B 605M 2024-12
Pfizer USD 88.2B 4.08B 2024-12
Regeneron Pharmaceuticals USD 29.35B 27.7M 2024-12
Roche Holding CHF 36.16B 3.28B 2024-12
Sarepta Therapeutics USD 1.53B 306.67M 2024-12
TG Therapeutics USD 222.36M 30.21M 2024-12
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12



Dynavax Technologies Eget Kapital Och Reservfonder - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Apr 2025.